Baby Elon

Baby Elon

TBA
1,805 Views
Baby Elon is a community driven token that runs on Binance Smart Chain. Our mission is to ``Lift Baby Elon to New Heights`` by offering investors an innovative, user-friendly, one-stop-shop to Stake and Trade NFTs & indulge in our P2E games. By utilizing a platform with a decentralized blockchain, to give every person in the world an equal chance to manage and improve their financial security.
1.9
TOTAL SCORE
3.1
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
Dates: TBA
Token info
Ticker: BABY
Platform: Binance Chain
Token Type: BEP-20
Financial
ICO Price: 0.00013 USD
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
ReverseDAO
ReverseDAO is a solution to all of the problems above; it is a platform that connects the Metaverse with real-world assets. Fiat and economic units that are bound with world assets can now be represented, stored, and transferred onto the blockchain just as easily as cryptocurrencies.
Upcoming
Coolomat
Coolomat Market will change the online e-commerce grocery sector with an innovative approach connecting customers and producers, big and small, over a new innovative online platform utilizing blockchain technology and open source software. A big “game changer” is the connection to physical click & collect pick up point devices – Coolomats. Our devices present the first and the only worldwide network of such kind.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.
Upcoming
FinanceX
The FinanceX exchange platform enables users to trade using the local currency from a range of countries. This makes trading faster and easier as users can buy/sell cryptocurrencies directly instead of a slower and more difficult method using an intermediate, such as BTC or ETH. It also means that users can trade from many different countries with no added difficulty, setting us apart from other exchanges.
Upcoming
RAVELOUS
Ravelous is the crypto ecommerce marketplace that lets users sell their stuff online for crypto. Sellers can accept many types of payments from buyers, and withdraw your balance in the token of their choosing. Buyers who do not have the currency the sellers prefer can exchange their coins for RAVE tokens which used for payment. The RAVE tokens can also be traded for other coins, and will have a value backed by the crypto-marketplace and the RAVE treasury that will increase over time as the treasury grows in value.
Upcoming
Little Phil
Powered by blockchain technology, the little Phil platform is an entirely new way of giving that fixes trust issues with charities using a public ledger, smart contracts and unique digital identities (UDID) to provide givers with the Proof of Need and Proof of Impact required to re-establish trust in giving to charity. Little Phil uses blockchain technology and user experience (UX) designed around a positive psychology framework to allow people to have the oversight, control and emotional connection of a philanthropist, without giving large amounts. People are able to give on their terms through their smartphone and track their giving all the way to the moment it’s received. This will create an engaging experience that makes them genuinely feel the positive impact they have had on their cause. In addition to this, charities will have solutions to their fundraising and exploitation concerns at a much lower cost than they currently incur.